产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 25164 | Lersivirine | 473921-12-9 | 98% Min. |  |
| Lersivirine, also known as UK-453061, is a novel second-generation non-nucleoside rev | ||||
| 25080 | LOXO-435 | 2833703-74-3 | ≧98.0% |  |
| LOXO-435是FGFR3的选择性小分子抑制剂。它对野生型和致癌激活的FGF | ||||
| 25075 | LLL12 | 1260247-42-4 | ≧97.0% |  |
| LLL12是一种强效的STAT3抑制剂。LLL12在小鼠异种移植物模型中显示出 | ||||
| 25052 | Lazertinib mesylate | 2247995-37-3 | ≧98.0% |  |
| Lazertinib是一种口服的第三代选择性表皮生长因子受体（EGFR）抑制 | ||||
| 24121 | LP-184 | 924835-67-6 | 98% Min. |  |
| LP-184 is an acylfulvene-derived prodrug activated by the oxidoreductase PTGR1 that a | ||||
| 24113 | Lirafugratinib HCl | 2688040-45-9 | 98% Min. |  |
| Lirafugratinib, also known as RLY-4008, is a tyrosine kinase inhibitor with potential | ||||
| 24107 | LXH-3-71 | 2251753-65-6 | ≧97.0% |  |
| LXH-3-71是一种新型“分子胶”，可诱导PHGDH和DDB1-CUL4泛素连接酶之 | ||||
| 24103 | LTGO-33 | 2834106-06-6 | 98% Min. |  |
| LTGO-33 is a selective, state-independent, and potent preclinical small molecule NaV1 | ||||
| 24093 | Limertinib | 1934259-00-3 | 98% Min. |  |
| Limertinib, also known as ASK120067, is an EGFR inhibitor. ASK120067 displayed potent | ||||
| 24080 | Lunresertib | 2719793-90-3 | 98% Min. |  |
| Lunresertib, alsop known as RP-6306, is a potent and selective PKMYT1 inhibitor (IC50 | ||||
| 24066 | Lartesertib | 2495096-26-7 | 98% Min. |  |
| Lartesertib（M4076）是丝氨酸/苏氨酸蛋白激酶ATM的强效抑制剂。 | ||||
| 24054 | Lasofoxifene tartrate | 190791-29-8 | 98% Min. |  |
| Lasofoxifene, also known as CP 336156, is a non-steroidal selective estrogen receptor | ||||
| 24053 | Lasofoxifene | 180916-16-9 | 98% Min. |  |
| Lasofoxifene, also known as CP 336156, is a non-steroidal selective estrogen receptor | ||||
| 24039 | Ladarixin | 849776-05-2 | ≧98.0% |  |
| Ladarixin（DF-2156；DF-2156A）是一种口服活性、变构非竞争性和双CXCR | ||||
| 24030 | Lipofermata | 297180-15-5 | 98% Min. |  |
| Lipofermata is a fatty acid transport protein 2(FATP2)inhibitor. Lipofermata shows fa | ||||
| 20654 | Lorundrostat | 1820940-17-7 | 98% Min. |  |
| Lorundrostat is an aldosterone synthase inhibitor. | ||||
| 20588 | Losmapimod | 585543-15-3 | 98% Min. |  |
| Losmapimod, also know as GW856553 or GW856553X or GSK-AHAB, is a drug developed by Gl | ||||
| 20577 | LY-3522348 | 2568608-48-8 | ≧98.0% |  |
| LY-3522348是一种酮己糖激酶（KHK）抑制剂. | ||||
| 20551 | Lin281632 | 108825-65-6 | 98% Min. |  |
| Lin28 1632, is a RNA binding protein Lin28 inhibitor. Lin281632 promotes mESC differe | ||||
| 20477 | LQZ-7I | 195822-23-2 | 98% Min. |  |
| LQZ-7I is a malarial protease PfSUB1 inhibitor. LQZ-7I showed significantly improved | ||||
| 20461 | LSN2463359 | 1401031-52-4 | 98% Min. |  |
| LSN2463359 is a novel positive allosteric modulators of the mGlu₅ receptor. | ||||
| 20438 | LFM-A13 | 244240-24-2 | 98% Min. |  |
| LFM-A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK). LF | ||||
| 20266 | Linzagolix | 935283-04-8 | ≧98.0% |  |
| Linzagolix 是一种新型的口服 GnRH 受体拮抗剂，可有效治疗子宫内膜 | ||||
| 21244 | LY-3475070 | 2375815-63-5 | 98% Min. |  |
| LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alo | ||||
| 210507 | LP-261 | 915412-67-8 | ≧98.0% |  |
| LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine sit | ||||
| 21225 | LM11A-31 HCl | 1243259-19-9 | 98% Min. |  |
| 20113001 | LVN84663 | 103784-66-3 | 98% Min. |  |
| LVN84663 is a useful reagent for determination of blood coagulating protease. It was | ||||
| 2091908 | LUN42518 | 47142-51-8 | 98% Min. |  |
| LUN42518, also known as Phentolamine Analogue 1, is an analogue of phentolamine. Phen | ||||
| 2073106 | Lerociclib HCl (G1T38 HCl) | 2097938-59-3 | ≧98.0% | _2097938-59-3.png) |
| Lerociclib HCl (G1T38 dihydrochloride)是一种分化型口服CDK4 / 6抑制剂，对 | ||||
| 2071524 | Lixivaptan | 168079-32-1 | 98% Min. |  |
| Lixivaptan, laso known as CRTX-080; VPA-985; WAY-VPA-985, is a potent, orally active, | ||||